Norma Treviere and Ritonovir: Effective Treatment for Chronic Lymphocytic Leukemia During the Omicron Surge

The final article is titled Effectiveness of Nirmatrelivir plus Ritonovir Treatment for Patients with Chronic Lymphocytic Leukemia During the Omicron Surge. The first author is Tamar Todd Moore of Benet's Iron Medical Center in Haifa, Israel. In patients with CLL, infections have long been a major driver of morbidity and leading cause of death. All together, these are important insights into molecular mechanisms underlying this rare and aggressive leukemia subtype.